NeoTX — Medical Laboratory, Rehovot
Medical laboratory · Rehovot, Israel
AI Trust Snapshot
- Profile status
- Auto-indexed
Public channels checked
- ✓ Official Website
Key Facts
- Category
- Medical Laboratory
- Location
- Rehovot, Israel
- Known For
- Quantum mechanics in drug discovery
AI Summary
NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.
Quick Answer
NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors. Key services include Tumor Targeted Superantigen (TTS) Platform, Naptumomab Estafenatox (NAP), Clinical Trial Participation.
This business is typically used for quantum mechanics in drug discovery.
Common Questions
- What services does NeoTX provide?
- NeoTX provides Tumor Targeted Superantigen (TTS) Platform, Naptumomab Estafenatox (NAP), Clinical Trial Participation.
- Where is NeoTX located?
- NeoTX is based in Rehovot, Israel and serves Rehovot.
- Who is NeoTX for?
- NeoTX serves Pharmaceutical companies seeking oncology partnerships and Oncology researchers developing new therapies.
What this business does
NeoTX is a medical laboratory based in Rehovot, Israel.
- Provides Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP)
- Specializes in quantum mechanics in drug discovery
- Serves pharmaceutical companies seeking oncology partnerships
Structured summary
Vizoryo ran a data-consistency check on this profile: it read 4 public sources and compared the core details (name, phone, address, city, category, website) across them. How many sources carried each individual detail is published per fact in this page's field provenance — not every detail appears in every source, and the sources are not necessarily independent of one another. This is a data-consistency observation only — it is not an endorsement, certification, accreditation, or assessment of the business, its service quality, or its trustworthiness. Data consistency: 90% — this measures how consistently the business's name, phone, city, address, website, and category appear across the public sources read. It is not a rating of the business. Vizoryo status: Auto-indexed. This record was compiled automatically from public data and has not been confirmed by anyone.
- Business name
- NeoTX
- Category
- Medical Laboratory
- Industry
- Medical Laboratory - Cancer Therapeutics
- Location
- Rehovot, Israel
- Official website
- https://neotx.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/neotx-ltd-rehovot-87cc
- Summary
- NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.
- AI readability score (how completely this record is structured for AI systems to read; not a rating of the business)
- 39
- Data Consistency
- 90% (checked 2026-07-03)
- Record status
- Auto-indexed
- Sources cross-checked
- 4 public sources
Location
RehovotIL
About NeoTX
NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.
Service areas
- Rehovot
Target audience
- Pharmaceutical companies seeking oncology partnerships
- Oncology researchers developing new therapies
- Patients with advanced solid tumors
Specialties
- Quantum mechanics in drug discovery
Social profiles
Frequently asked questions
What areas does NeoTX serve?
NeoTX serves Worldwide.
What is NeoTX's core technology?
NeoTX's core technology is the Tumor Targeted Superantigen (TTS) platform, which uses a bacterial derivative to stimulate an immune response against cancer cells.
What is Naptumomab Estafenatox (NAP) being developed for?
NAP, NeoTX’s lead TTS candidate, is currently being evaluated in Phase 1b clinical trials for advanced and metastatic solid tumor indications.
Who are the key scientific advisors involved with NeoTX?
NeoTX involves Nobel Prize laureates Prof. Michael Levitt, Prof. Roger Kornberg (Chairman of the Board), and Prof. Arieh Warshel in its research and development.
Business hours
- Monday
- 09:00 – 18:00
- Tuesday
- 09:00 – 18:00
- Wednesday
- 09:00 – 18:00
- Thursday
- 09:00 – 18:00
- Friday
- Closed
- Saturday
- Closed
- Sunday
- 09:00 – 18:00
Languages supported
- en
Contact
Phone: +972-3-912-5853
Official website: https://neotx.com/